Two Sigma Investments, LP Cardiff Oncology, Inc. Transaction History

Two Sigma Investments, LP

$59 Billion
Q3 2025

A detailed history of Two Sigma Investments, LP transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 204,010 shares of CRDF stock, worth $438,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares

204,010

Previous 443,521 54.0%

Holding current value

$438,621

Previous $1.4 Million 70.51%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.96 - $4.51 $469,441 - $1.08 Million	-239,511 Reduced 54.0%	204,010 $412,000
Q2 2025 Aug 14, 2025	BUY	$2.38 - $4.3 $654,909 - $1.18 Million	275,172 Added 163.45%	443,521 $1.4 Million
Q1 2025 May 15, 2025	BUY	$3.14 - $4.75 $198,203 - $299,829	63,122 Added 59.99%	168,349 $528,000
Q4 2024 Feb 14, 2025	SELL	$2.31 - $5.35 $183,289 - $424,501	-79,346 Reduced 42.99%	105,227 $456,000
Q3 2024 Nov 14, 2024	SELL	$2.05 - $2.77 $69,814 - $94,335	-34,056 Reduced 15.58%	184,573 $492,000

Q2 2024 Aug 14, 2024	BUY	$2.22 - $5.89 $434,369 - $1.15 Million	195,662 Added 851.93%	218,629 $485,000
Q1 2024 May 15, 2024	SELL	$1.46 - $5.91 $11,242 - $45,507	-7,700 Reduced 25.11%	22,967 $122,000
Q4 2023 Feb 14, 2024	SELL	$0.96 - $1.55 $21,696 - $35,030	-22,600 Reduced 42.43%	30,667 $45,000
Q3 2023 Nov 14, 2023	SELL	$1.38 - $2.18 $55,151 - $87,123	-39,965 Reduced 42.87%	53,267 $74,000
Q2 2023 Aug 14, 2023	BUY	$1.37 - $1.95 $86,627 - $123,302	63,232 Added 210.77%	93,232 $137,000
Q1 2023 May 15, 2023	BUY	$1.45 - $2.09 $9,701 - $13,984	6,691 Added 28.71%	30,000 $49,000
Q4 2022 Feb 14, 2023	BUY	$1.22 - $1.66 $28,436 - $38,692	23,309 New	23,309 $32,000
Q2 2022 Aug 15, 2022	SELL	$1.17 - $2.61 $531,563 - $1.19 Million	-454,328 Reduced 97.42%	12,019 $26,000
Q1 2022 May 16, 2022	BUY	$2.11 - $7.25 $187,743 - $645,090	88,978 Added 23.58%	466,347 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$5.18 - $7.24 $1.18 Million - $1.65 Million	-227,381 Reduced 37.6%	377,369 $2.27 Million
Q3 2021 Nov 15, 2021	SELL	$5.01 - $7.58 $520,629 - $787,698	-103,918 Reduced 14.66%	604,750 $4.03 Million
Q2 2021 Aug 16, 2021	SELL	$6.65 - $10.04 $108,335 - $163,561	-16,291 Reduced 2.25%	708,668 $4.71 Million
Q1 2021 May 17, 2021	BUY	$9.1 - $19.57 $3.51 Million - $7.54 Million	385,277 Added 113.42%	724,959 $6.71 Million
Q4 2020 Feb 16, 2021	BUY	$12.02 - $24.71 $4.08 Million - $8.39 Million	339,682 New	339,682 $6.11 Million

Others Institutions Holding CRDF

# of Institutions

124

Shares Held

21.8M

Call Options Held

1.11M

Put Options Held

150K

View Full List

About Cardiff Oncology, Inc.

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $93.2M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

More about CRDF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Cardiff Oncology, Inc. Transaction History